Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Human Papillomavirus Vaccines
Researchers from University of Cape Town, Institute of Infectious Disease and Molecular Medicine detail findings in human papillomavirus vaccines
March 4th, 2009
A new study, 'Insights into the role and function of L2, the minor capsid protein of papillomaviruses,' is now available. According to a study from Cape Town, South Africa, "Human papillomaviruses (HPV) are responsible for the most common human sexually transmitted viral infections, and high-risk types are responsible for causing cervical and other cancers. The minor capsid protein L2 of HPV plays important roles in virus entry into cells, localisation of viral components to the nucleus, in DNA binding, capsid formation and stability." "It also elicits antibodies that are more cross-reactive between HPV types than does the major capsid protein L1, making it an...
Source: Vaccine Weekly (2009-03-04)
|
